Back to Search

EXEL

Exelixis Inc
Data: 2026-03-30
$42.02
Price
1.18%
Change
$49.62
52W High
$32.38
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Quick Stats
Mar 30, 2026

62.2

AI Score

BUY

0.07

Volume Ratio

May 12, 2026

Next Earnings

15

+ve Days (30d)

14

-ve Days (30d)

EXEL Stock Summary

Last updated

EXEL is currently trading at $42.02, positioned above its 200-day moving average of $41.56, indicating a long-term uptrend. The stock has a 52-week range of $32.38 to $49.62.

Technical Analysis: The 50-day moving average stands at $42.74, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates EXEL at 62.2/100 with a BUY recommendation.

EXEL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

EXEL Price vs Max Options Open Interest
EXEL Max Change In Options Open Interest

EXEL Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

EXEL Daily Out of Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

EXEL Daily In the Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

EXEL Most Active Options by Volume(near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Exelixis Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

EXEL Moving Averages Analysis

Exelixis Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Mar 30, 2026

EXEL (Exelixis Inc) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 41.73
20 41.57
30 42.37
50 42.74
100 42.96
200 41.56

EXEL Fundamental Analysis

P/E (Forward) 13.245
P/E (Trailing) 15.4036
Market Cap ($) 11.4 billion
Earnings/Share ($) 2.75
Net Proft Margin (%) 0.3373
Dividend/Share ($) --
EPS Estimate Current Year ($) 3.3956
EPS Estimate Next Year ($) 3.9294
WallStreet Target Price ($) 46.8333
Most Recent Quarter